We consider the GI cancers as well-known inflammation-associated cancers and don't address just the damaging effects of α7nAChR signaling in GI carcinogenesis, but somewhat concentrate on the anti-inflammatory functions of this receptor. This evidence concerns the gene CHRNA7 and cancer.